Brenner Tumor Completed Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Brenner tumour

IndicationStatusPhase
DBCOND0000999 (Brenner Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00085358Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)Treatment
NCT00079430Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerTreatment